Literature DB >> 9444023

Cardiovascular manifestations and left ventricular functions in human immunodeficiency virus infection in infants and children in Thailand.

C Pathmanand1, K Anuroj, C Thisyakorn, V Sueblinvong.   

Abstract

During January through December 1993, twelve symptomatic infants and children (6 females, 6 males) with human immunodeficiency virus infection were prospectively evaluated for their cardiovascular clinical manifestations and ventricular functions, using two-dimensional, M-mode and Doppler echocardiographic examination. From auscultation, the pulmonic component of the second heart sound was accentuated in 8 cases and the murmur of atrioventricula valve regurgitation and pericardial friction rub were audible in 7 and 6 patients, respectively. Cardiomegaly and venous congestion were present on chest roentgenogram in 6 cases and electrocardiogram was abnormal in 5. The echocardiogram demonstrated elevated pulmonary arterial pressure in 9 patients. There were 5 cases of non-tamponade pericardial effusion. Five patients had mitral and pulmonary insufficiency while six had tricuspid insufficiency. The ejection fraction and shortening fraction were increased in all. The incidence of pulmonary hypertension was more frequent than previously reported.

Entities:  

Mesh:

Year:  1997        PMID: 9444023

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  2 in total

Review 1.  Pulmonary Arterial Hypertension among HIV-Infected Children: Results of a National Survey and Review of the Literature.

Authors:  Arnaud Grégoire L'Huillier; Klara Maria Posfay-Barbe; Hiba Pictet; Maurice Beghetti
Journal:  Front Pediatr       Date:  2015-04-07       Impact factor: 3.418

2.  Electrocardiographic abnormalities in treatment-naïve HIV subjects in south-east Nigeria.

Authors:  Innocent Chukwuemeka Okoye; Ernest Ndukaife Anyabolu
Journal:  Cardiovasc J Afr       Date:  2017-03-23       Impact factor: 1.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.